Pengetahuan Dan Minat Vaksinasi Covid-19 Masyarakat di Kota Gorontalo dan Kabupaten Bone Bolango
Abstract
Keywords
Full Text:
PDFReferences
Budiman dan Riyanto A (2013). Kapita Selekta Kuisoner. Jakarta: Salemba Medika.
Flaxman, S., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., . . . Bhatt, S. (2020). Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature, 584(7820), 257-261. doi:10.1038/s41586-020-2405-7
Fontanet, A., & Cauchemez, S. (2020). COVID-19 herd immunity: where are we? Nature Reviews Immunology, 20(10), 583-584.
Johns Hopkins University and Medicine (2021). Covid-19 Dashboard by the Center for System Science and Engineering (CSSE). Baltimore:Johns Hopkins University and Medicine
Kementerian Kesehatan Republik Indonesia (2021). Frequently Asked Question : Seputar Pelaksanaan Vaksinasi COVID-19.
Kementerian Kesehatan Republik Indonesia (2021). Vaksinasi COVID-19 Nasional.
Larson, H. J., Jarrett, C., Schulz, W. S., Chaudhuri, M., Zhou, Y., Dube, E., . . . Wilson, R. (2015). Measuring vaccine hesitancy: The development of a survey tool. Vaccine, 33(34), 4165-4175. doi:10.1016/j.vaccine.2015.04.037
Makmun, A. and Hazhiyah, S. F. (2020) ‘Tinjauan Terkait Pengembangan Vaksin Covid 19’, Molucca Medica, 13, pp. 52–59. doi: 10.30598/molmed.2020.v13.i2.52
Notoatmodjo, S (2012). Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta
Ophinni, Y., Hasibuan, A. S., Widhani, A., Maria, S., Koesnoe, S., Yunihastuti, E., . . . Djauzi, S. (2020). COVID-19 Vaccines: Current Status and Implication for Use in Indonesia. Acta Med Indones, 52(4), 388-412.
Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020). High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis, 26(7), 1470-1477. doi:10.3201/eid2607.200282
Slameto (2015). Belajar dan Faktor-faktor yang mempengaruhinya. Jakarta; Rineka Cipta
Sun, P., Lu, X., Xu, C., Sun, W., & Pan, B. (2020). Understanding of COVID-19 based on current evidence. J Med Virol, 92(6), 548-551. doi:10.1002/jmv.25722
WHO (2020). Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. A systematic review of asymptomatic infections. https://www.who.int/publications-detail/clinicalmanagement-of-severe-acute-respiratory- infection-whennovel-coronavirus-(ncov)-infection-is-suspected.
WHO. Whats herd immunity?official Covid 19 updates. 31 Dec. 2020. http://www/who.int/herd/immunity
Wulanningrum, H. (2021). Evaluasi Diseminasi Informasi Vaksinasi Covid-19 Melalui Media Sosial Kementerian Komunikasi dan Informatika. Dinamika dan Strategi Humas Pemerintah di Indonesia Pranata Humas Indonesia 2021, 72.
Zhang, Y., Zeng, G., Pan, H., Li, C., Hu, Y., Chu, K., . . . Zhu, F. (2021). Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis, 21(2), 181-192. doi:10.1016/s1473-3099(20)30843-4
Priastuty, C. W. et al (2020) . Hoaks tentang Vaksin Covid-19 di Tengah Media Sosial. Prosiding Seminar Nasional Unimus, 3, pp. 391–399.
DOI: https://doi.org/10.37311/jnj.v4i1.13476
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Jambura Nursing Journal